Cargando…
Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
BACKGROUND: Hepatocellular carcinoma as a complication is linked to improved outcomes of thalassemia. MAIN BODY: Published data suggest an incidence of HCC in thalassemia of about 2%. However, since thalassemia is endemic in many under-developed countries where patients have not probably been screen...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724702/ https://www.ncbi.nlm.nih.gov/pubmed/33297979 http://dx.doi.org/10.1186/s12876-020-01542-2 |